Nikola Kotur

7PUBLICATIONS
19CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersAllergyFood properties (incl. characteristics and health benefits)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 21, 2026
Association of Variants in Candidate Pharmacogenes with Response to Mercaptopurine and Methotrexate in Pediatric Acute Lymphoblastic Leukemia: A Single-Center Experience from Croatia.

|Jan 10, 2026
Correction: Tosic et al. High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia. Int. J. Mol. Sci. 2025, 26, 1153.

Natasa Tosic, Kristina Tomic Vujovic, Vojin Vukovic

|Feb 13, 2025
High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia.

Natasa Tosic, Kristina Tomic Vujovic, Vojin Vukovic

|Aug 27, 2024
Psychological Distress Is Associated With Inflammatory Bowel Disease Manifestation and Mucosal Inflammation.

Sanja Dragasevic, Biljana Stankovic, Nikola Kotur

|Oct 27, 2022
Genetic Aspects of Micronutrients Important for Inflammatory Bowel Disease.

Sanja Dragasevic, Biljana Stankovic, Nikola Kotur

|Sep 28, 2021
Machine Learning Modeling from Omics Data as Prospective Tool for Improvement of Inflammatory Bowel Disease Diagnosis and Clinical Classifications.

Biljana Stankovic, Nikola Kotur, Gordana Nikcevic

Pageof 2

Frequent Collaborators

5 joint publications

Biljana Stankovic

2 joint publications

Branka Zukic

2 joint publications

Sanja Dragasevic

2 joint publications

Natasa Tosic